Company intelligence / Profile preview

Viromed Medical

Hamburg, Germany

Ownership: Private
Development stage: Other

Overview

Viromed Medical AG has developed and commercialized cold atmospheric plasma technology products for air purification and wound therapy, showing potential to protect against infection and improve wound healing, with recent data suggesting a reduction in death rates in ventilated patients.

Therapeutic areas: Infectious DiseasesDermatology
Modalities: DeviceCold atmospheric plasma therapy
Industry: Therapeutic Medical Devices

Partnerships

Tripart Titan GmbH & Co KG (distribution partnership for ViroCAP and PulmoPlas in Turkey)

Beyond the preview

Go deeper on Viromed Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viromed Medical.

Explore the full profile